Acrivon Therapeutics (ACRV) Stock Chart & Stock Price History $8.01 +0.01 (+0.13%) (As of 11/1/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Acrivon Therapeutics Stock Price Performance5 Day Performance-1.96%1 Month Performance+12.66%3 Month Performance+6.09%6 Month Performance-5.32%Year-To-Date Performance+62.80%1 Year Performance+48.88% Receive ACRV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Acrivon Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. ACRV Stock Chart for Saturday, November, 2, 2024 ACRV Chart by TradingView Acrivon Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/01/2024$8.00$8.01+0.12%$8.13$7.9235,926 shs$248.07 million10/31/2024$8.35$8.00-4.19%$8.33$7.9836,018 shs$247.78 million10/30/2024$8.27$8.35+0.97%$8.46$8.1626,495 shs$257.82 million10/29/2024$8.17$8.27+1.22%$8.30$8.0929,890 shs$255.35 million10/28/2024$7.96$8.17+2.64%$8.25$7.9549,496 shs$252.27 million10/25/2024$8.03$7.96-0.87%$8.03$7.9340,448 shs$245.78 million Get the Latest News and Ratings for ACRV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acrivon Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/24/2024$8.06$8.03-0.37%$8.16$7.9527,869 shs$247.94 million10/23/2024$8.05$8.06+0.12%$8.11$7.9074,843 shs$248.87 million10/22/2024$8.05$8.05$8.24$7.9749,902 shs$248.56 million10/21/2024$8.25$8.05-2.42%$8.27$7.9427,540 shs$248.56 million10/18/2024$7.87$8.25+4.83%$8.36$7.7771,807 shs$254.74 million10/17/2024$7.75$7.87+1.55%$8.13$7.5855,071 shs$243.00 million10/16/2024$7.60$7.75+1.97%$8.16$7.5988,656 shs$239.30 million10/15/2024$7.26$7.60+4.68%$7.70$7.1881,438 shs$234.67 million10/14/2024$7.29$7.26-0.41%$7.30$7.0154,627 shs$224.17 million10/11/2024$6.98$7.29+4.44%$7.29$6.9166,270 shs$225.09 million10/10/2024$6.99$6.98-0.14%$7.09$6.8767,187 shs$215.52 million10/09/2024$7.00$6.99-0.14%$7.08$6.9480,303 shs$215.83 million10/08/2024$6.94$7.00+0.86%$7.10$6.91201,698 shs$216.14 million10/07/2024$7.01$6.94-1.00%$7.10$6.8947,997 shs$214.29 million10/04/2024$6.89$7.01+1.74%$7.17$6.85111,907 shs$216.45 million10/03/2024$7.11$6.89-3.09%$7.12$6.88113,927 shs$212.74 million10/02/2024$6.98$7.11+1.86%$7.18$6.8786,523 shs$219.54 million10/01/2024$7.00$6.98-0.29%$7.18$6.8793,070 shs$215.52 million09/30/2024$7.16$7.00-2.23%$7.26$6.95100,705 shs$216.14 million09/27/2024$7.26$7.16-1.38%$7.38$7.1440,426 shs$221.08 million09/26/2024$7.17$7.26+1.26%$7.55$7.0684,853 shs$224.17 million09/25/2024$7.19$7.17-0.28%$7.24$7.0340,200 shs$221.39 million09/24/2024$7.23$7.19-0.55%$7.31$7.0052,666 shs$222.01 million09/23/2024$7.47$7.23-3.21%$7.68$7.11102,472 shs$223.24 million09/20/2024$7.59$7.47-1.58%$7.71$7.33519,213 shs$230.65 million09/19/2024$7.56$7.59+0.40%$7.85$7.40126,665 shs$234.36 million09/18/2024$7.60$7.56-0.53%$7.82$7.20232,368 shs$233.43 million09/17/2024$8.23$7.60-7.65%$8.43$7.53211,539 shs$234.67 million09/16/2024$8.91$8.23-7.63%$10.00$8.14565,637 shs$254.12 million09/13/2024$9.24$8.91-3.57%$9.40$8.6587,061 shs$275.94 million09/12/2024$9.50$9.24-2.74%$9.99$9.15144,833 shs$285.30 million09/11/2024$8.58$9.50+10.72%$9.58$8.1496,153 shs$293.33 million09/10/2024$7.90$8.58+8.61%$8.89$7.91145,050 shs$265.72 million09/09/2024$8.08$7.90-2.23%$8.25$7.9039,694 shs$244.66 millionElon knows the truth, which is why they want him silenced (Ad)Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. Watch this new documentary and you’ll discover what Elon knows,09/06/2024$8.06$8.08+0.25%$8.34$7.9163,743 shs$249.49 million09/05/2024$8.20$8.06-1.71%$8.33$7.7593,475 shs$248.87 million09/04/2024$8.42$8.20-2.61%$8.69$8.1540,779 shs$253.19 million09/03/2024$9.49$8.42-11.28%$9.47$8.4238,033 shs$259.98 million09/02/2024$9.49$9.49$10.16$8.9275,900 shs$293.02 million08/30/2024$9.98$9.49-4.91%$10.16$8.9275,924 shs$293.02 million08/29/2024$9.27$9.98+7.66%$10.00$9.37196,754 shs$308.15 million08/28/2024$9.18$9.27+0.98%$9.34$9.0541,641 shs$286.23 million08/27/2024$9.46$9.18-2.96%$9.53$9.0336,354 shs$283.45 million08/26/2024$9.36$9.46+1.07%$10.00$9.4095,945 shs$292.10 million08/23/2024$8.69$9.36+7.71%$9.38$8.8739,812 shs$289.01 million08/22/2024$9.19$8.69-5.44%$9.25$8.6124,394 shs$268.32 million08/21/2024$9.03$9.19+1.77%$9.42$8.8172,086 shs$283.76 million08/20/2024$8.33$9.03+8.40%$9.23$8.3581,314 shs$278.82 million08/19/2024$7.60$8.33+9.61%$8.40$7.4550,429 shs$257.21 million08/16/2024$7.23$7.60+5.12%$7.72$7.1131,040 shs$234.67 million08/15/2024$7.02$7.23+2.99%$7.60$6.9437,015 shs$223.24 million08/14/2024$7.25$7.02-3.17%$7.35$7.0146,972 shs$216.76 million08/13/2024$7.59$7.25-4.48%$7.73$7.2362,056 shs$223.86 million08/12/2024$7.69$7.59-1.30%$7.78$7.4238,419 shs$234.36 million08/09/2024$7.18$7.69+7.10%$7.69$7.1144,232 shs$237.44 million08/08/2024$6.99$7.18+2.72%$7.30$6.9044,288 shs$221.70 million08/07/2024$7.19$6.99-2.78%$7.38$6.8950,584 shs$215.83 million08/06/2024$7.38$7.19-2.57%$7.45$7.1560,917 shs$222.01 million08/05/2024$7.55$7.38-2.25%$7.49$7.09115,984 shs$233.12 million08/02/2024$7.81$7.55-3.33%$7.75$7.4658,342 shs$233.14 million08/01/2024$8.38$7.81-6.80%$8.30$7.7270,743 shs$241.17 million Related Companies Arcutis Biotherapeutics Stock Chart Applied Therapeutics Stock Chart Prothena Stock Chart Cullinan Therapeutics Stock Chart Zymeworks Stock Chart Phibro Animal Health Stock Chart Rapport Therapeutics Stock Chart Pliant Therapeutics Stock Chart Tyra Biosciences Stock Chart AnaptysBio Stock Chart Receive ACRV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Acrivon Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ACRV) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt...Porter & Company | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acrivon Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acrivon Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
